Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Harris, Necole
NCT05667662 / 2022-002289-33: Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA	Terminated	2	8	Europe, US, RoW	Itraconazole Powder, PUR1900, Placebo	Pulmatrix Inc., Pulmatrix, Inc.	ABPA	02/24	02/24
ZEVR, NCT04186546: Zephyr Valve Registry	Active, not recruiting	N/A	150	US	Zephyr Valve Procedure, Zephyr Endobronchial Valve, Endobronchial Valve, Bronchoscopic Lung Volume Reduction, BLVR	Pulmonx Corporation	Emphysema	12/24	12/26
AIRFLOW-3, NCT03639051: Evaluation of the Safety and Efficacy of TLD in Patients with COPD	Active, not recruiting	N/A	464	Europe, US	Targeted Lung Denervation (TLD), TLD, TLD Therapy, Optimal Medical Care	Nuvaira, Inc.	COPD	10/24	09/28
Curtiss, Miranda
NCT05667662 / 2022-002289-33: Study to Evaluate Itraconazole Administered as Inhaled Dry Powder in Adults With Asthma and ABPA	Terminated	2	8	Europe, US, RoW	Itraconazole Powder, PUR1900, Placebo	Pulmatrix Inc., Pulmatrix, Inc.	ABPA	02/24	02/24